Q5150 Injection, aflibercept-mrbb, 1 milligrams
Q-Codes
Also known as: aflibercept biosimilar, Fabhalta, VEGF inhibitor, anti-VEGF
Injection of aflibercept-mrbb (Fabhalta), a biosimilar to aflibercept, administered at 1 milligram per dose.
Clinical Context
Used for wet age-related macular degeneration treatment with intravitreal administration. Provides vascular endothelial growth factor inhibition for neovascular disease management.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.